Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B McArdle

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Journal of Cellular and Molecular Medicine|November 29, 2023
Anticancer actions of carnosine in cellular models of prostate cancerK Habra, J R D Pearson, P Le Vu, et al.
Vaccine|August 19, 2004
Anti-tumour therapeutic efficacy of OX40L in murine tumour modelSelman A Ali, Murrium Ahmad, June Lynam, et al.
Cancer Immunology, Immunotherapy : CII|May 10, 2007
HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptidesMorgan G Mathieu, Ashley J Knights, Graham Pawelec, et al.
European Journal of Immunology|December 17, 2013
Novel prostate acid phosphatase-based peptide vaccination strategy induces antigen-specific T-cell responses and limits tumour growth in miceJaimy M S Saif, Jayakumar Vadakekolathu, Shraddha S Rane, et al.
Journal of Medicinal Chemistry|December 4, 2023
Small Molecule Ligands of the BET-like Bromodomain, <i>Sm</i>BRD3, Affect <i>Schistosoma mansoni</i> Survival, Oviposition, and DevelopmentMatthias Schiedel, Darius J B McArdle, Gilda Padalino, et al.
British Journal of Cancer|April 24, 2014
HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancerT M A Abdel-Fatah, S E B McArdle, C Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2015
HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression AnalysisTarek M A Abdel-Fatah, Stephanie E B McArdle, Devika Agarwal, et al.
Frontiers in Immunology|September 27, 2018
Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts Relapse of Triple Negative Breast CancerGemma A Foulds, Jayakumar Vadakekolathu, Tarek M A Abdel-Fatah, et al.
Genes, Chromosomes & Cancer|December 11, 2012
Identification of novel breast cancer-associated transcripts by UniGene database mining and gene expression analysis in normal and malignant cellsStéphanie A-S Laversin, Vinaya M Phatak, Des G Powe, et al.
Cancer Immunology, Immunotherapy : CII|July 2, 2024
TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumorsJoshua R D Pearson, Carles Puig-Saenz, Jubini E Thomas, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Journal of Cellular and Molecular Medicine|November 29, 2023
Anticancer actions of carnosine in cellular models of prostate cancerK Habra, J R D Pearson, P Le Vu, et al.
Vaccine|August 19, 2004
Anti-tumour therapeutic efficacy of OX40L in murine tumour modelSelman A Ali, Murrium Ahmad, June Lynam, et al.
Cancer Immunology, Immunotherapy : CII|May 10, 2007
HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptidesMorgan G Mathieu, Ashley J Knights, Graham Pawelec, et al.
European Journal of Immunology|December 17, 2013
Novel prostate acid phosphatase-based peptide vaccination strategy induces antigen-specific T-cell responses and limits tumour growth in miceJaimy M S Saif, Jayakumar Vadakekolathu, Shraddha S Rane, et al.
Journal of Medicinal Chemistry|December 4, 2023
Small Molecule Ligands of the BET-like Bromodomain, <i>Sm</i>BRD3, Affect <i>Schistosoma mansoni</i> Survival, Oviposition, and DevelopmentMatthias Schiedel, Darius J B McArdle, Gilda Padalino, et al.
British Journal of Cancer|April 24, 2014
HAGE (DDX43) is a biomarker for poor prognosis and a predictor of chemotherapy response in breast cancerT M A Abdel-Fatah, S E B McArdle, C Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2015
HAGE in Triple-Negative Breast Cancer Is a Novel Prognostic, Predictive, and Actionable Biomarker: A Transcriptomic and Protein Expression AnalysisTarek M A Abdel-Fatah, Stephanie E B McArdle, Devika Agarwal, et al.
Frontiers in Immunology|September 27, 2018
Immune-Phenotyping and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells From Patients With Breast Cancer: Identification of a 3 Gene Signature Which Predicts Relapse of Triple Negative Breast CancerGemma A Foulds, Jayakumar Vadakekolathu, Tarek M A Abdel-Fatah, et al.
Genes, Chromosomes & Cancer|December 11, 2012
Identification of novel breast cancer-associated transcripts by UniGene database mining and gene expression analysis in normal and malignant cellsStéphanie A-S Laversin, Vinaya M Phatak, Des G Powe, et al.
Cancer Immunology, Immunotherapy : CII|July 2, 2024
TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumorsJoshua R D Pearson, Carles Puig-Saenz, Jubini E Thomas, et al.
Pageof 9